A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Clinical trial NCT07678684 · RECRUITING
Trial details
- NCT number
- NCT07678684
- Sponsor
- HighField Biopharmaceuticals Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.